Faes Farma S.A. Logo

Faes Farma S.A.

Researches, develops, and markets pharmaceuticals and animal nutrition products.

FAE | MC

Overview

Corporate Details

ISIN(s):
ES0134950F36
LEI:
959800FXZQY7U3P1G969
Country:
Spain
Address:
AVENIDA AUTONOMIA, 10-, 48940 Leioa

Description

Faes Farma S.A. is a pharmaceutical company engaged in the research, development, manufacturing, and marketing of pharmaceutical products, healthcare solutions, and animal nutrition products. The company's pharmaceutical division develops treatments for conditions in therapeutic areas including allergy, gastroenterology, and immunology, with key proprietary molecules such as Bilastine, a leading antihistamine, and Calcifediol for Vitamin D deficiency. The animal nutrition business provides nutritional solutions and supplements for sustainable animal production. A core focus of the company is its investment in R&D to develop novel molecules and health solutions for its global markets.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-07-16 00:00
Acuerdo Junta Extraordinaria de Accionistas
Spanish 115.9 KB
2025-06-25 00:00
Aspectos relevantes de la Junta de Accionistas 2025
Spanish 159.0 KB
2025-06-25 00:00
Presentación Junta de Accionistas 2025
Spanish 4.2 MB
2025-06-11 00:00
Junta General Extraordinaria de Accionistas
Spanish 167.3 KB
2025-05-19 15:51
Convocatoria de la Junta General de Accionistas de 2025
Spanish 180.2 KB
2025-05-19 00:00
Convocatoria de la Junta General de Accionistas de 2025
Spanish 180.2 KB
2025-05-06 08:25
Informe de negocio del primer trimestre de 2025
Spanish 1.7 MB
2025-04-29 16:08
Faes Farma anuncia la celebración de un webcast para presentar los resultados d…
Spanish 65.2 KB
2025-04-22 11:39
Presentación Capital Markets Day 2025
Spanish 4.7 MB
2025-04-22 09:56
La Sociedad comunica que hoy celebrará su Capital Markets Day para presentar el…
Spanish 55.7 KB
2025-03-25 18:09
Faes Farma S.A. ha suscrito un contrato para la adquisición de Laboratorios Edo…
Spanish 67.7 KB
2025-02-28 07:55
Informe de negocio y resultados 2024
Spanish 1.2 MB
2025-02-28 07:52
La sociedad remite el Informe Anual de Gobierno Corporativo del ejercicio 2024
Spanish 426.0 KB
2025-02-28 07:51
La Sociedad remite el Informe Anual sobre remuneraciones de los consejeros del …
Spanish 213.3 KB
2025-02-28 00:00 Spanish 12.1 MB

Automate Your Workflow. Get a real-time feed of all Faes Farma S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Faes Farma S.A.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Faes Farma S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Acurx Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing a new class of antibiotics for priority pathogens.
United States of America
ACXP
Adaptimmune Therapeutics PLC Logo
Commercial-stage biopharma developing TCR T-cell therapies for solid tumors.
United States of America
ADAP
ADBIOTECH Co.,Ltd. Logo
Develops IgY-based immune antibodies as alternatives to vaccines and antibiotics.
South Korea
179530
ADC Therapeutics SA Logo
Commercial-stage biotech developing antibody-drug conjugates for cancer therapy.
United States of America
ADCT
Addex Therapeutics Ltd. Logo
Clinical-stage biopharma developing allosteric modulators for neurological disorders.
Switzerland
ADXN
ADIAL PHARMACEUTICALS, INC. Logo
A clinical-stage biopharma developing genetically targeted therapies for addiction.
United States of America
ADIL
Adicet Bio, Inc. Logo
Develops allogeneic gamma delta T cell therapies for cancer and autoimmune diseases.
United States of America
ACET
Adlai Nortye Ltd. Logo
A clinical-stage biopharma firm developing cancer immunotherapies and RAS-targeting drugs.
United States of America
ANL
ADMA BIOLOGICS, INC. Logo
Biopharmaceutical company that develops and manufactures plasma-derived biologics.
United States of America
ADMA
Adverum Biotechnologies, Inc. Logo
A clinical-stage company developing gene therapies for ocular diseases.
United States of America
ADVM

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.